| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 467.32B | 473.95B | 469.06B | 395.78B | 376.56B | 391.90B |
| Gross Profit | 72.44B | 70.70B | 64.63B | 57.89B | 57.36B | 55.54B |
| EBITDA | 48.71B | 47.71B | 44.19B | 38.42B | 39.00B | 38.61B |
| Net Income | 28.84B | 28.88B | 28.02B | 26.35B | 26.22B | 25.04B |
Balance Sheet | ||||||
| Total Assets | 463.43B | 488.47B | 503.28B | 446.41B | 378.40B | 366.53B |
| Cash, Cash Equivalents and Short-Term Investments | 75.76B | 71.70B | 98.55B | 67.53B | 40.01B | 50.91B |
| Total Debt | 24.46B | 23.72B | 35.34B | 37.56B | 14.26B | 15.77B |
| Total Liabilities | 148.67B | 176.31B | 212.15B | 183.39B | 137.20B | 144.79B |
| Stockholders Equity | 312.69B | 310.10B | 288.78B | 260.84B | 239.13B | 219.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.80B | 41.95B | 14.32B | 1.11B | 6.24B |
| Operating Cash Flow | 0.00 | 8.66B | 43.97B | 17.39B | 5.25B | 9.18B |
| Investing Cash Flow | 0.00 | -8.93B | -2.34B | -3.13B | -7.56B | -4.25B |
| Financing Cash Flow | 0.00 | -24.53B | -11.01B | 11.64B | -10.17B | -10.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥259.31B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
74 Outperform | ¥604.12B | 13.52 | 8.34% | 2.66% | 5.14% | 12.52% | |
72 Outperform | ¥699.53B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
72 Outperform | ¥1.29T | 12.95 | 14.94% | 2.00% | 16.43% | 53.76% | |
70 Outperform | ¥551.26B | 14.38 | ― | 2.51% | 15.47% | 64.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |